| Literature DB >> 29334929 |
Martin E Ekiti1,2, Jean-Berthelot Zambo3,4, Felix K Assah3, Valirie N Agbor5, Krystel Kekay3, Gloria Ashuntantang3.
Abstract
BACKGROUND: Agricultural workers especially in sugarcane plantations have a high risk of chronic kidney disease (CKD). Little is known about CKD among sugarcane plantation workers in Cameroon. This study sought to evaluate the prevalence and identify factors associated with CKD in sugarcane plantation workers in Cameroon.Entities:
Keywords: Cameroon; Chronic kidney disease; Sub-Saharan Africa; Sugarcane plantation workers
Mesh:
Year: 2018 PMID: 29334929 PMCID: PMC5769452 DOI: 10.1186/s12882-017-0798-9
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Fig. 1Participant recruitment flowchart – To make our sample population representative of the general working population we randomly selected pre-numbered workers such that the proportions, with respect to workspace, were respected at every stage. In the first stage, we selected 250 participants. After excluding 46, we retained 204 participants, ensuring that the proportions remained approximately the same
Characteristics of sugarcane plantation workers according to workspace in Mbandjock, Centre Region, Cameroon, 2016
| Variable | Total, n (%) | Office, n (%) | Factory, n (%) | Field, n (%) | |
|---|---|---|---|---|---|
| Sex | <0.001 | ||||
| Male | 153 (75.0) | 17 (73.9) | 55 (96.5) | 81 (65.3) | |
| Female | 51 (25.0) | 6 (26.1) | 2 (3.6) | 43 (34.7) | |
| Mean age (years) | 38.8 ± 9.8 | 40.6 ± 11.5 | 37.9 ± 9.1 | 38.9 ± 9.8 | 0.534 |
| Contract-type | <0.001 | ||||
| CDI | 38 (18.6) | 9 (39.1) | 15 (26.3) | 14 (11.3) | |
| CDD | 16 (7.8) | 4 (17.4) | 8 (14.0) | 4 (3.2) | |
| CDC | 150 (73.5) | 10 (43.5) | 34 (59.6) | 106 (85.5) | |
| Median duration of employment (years) | 10.0 ± 7.8 | 12.0 ± 9.0 | 10.0 ± 7.3 | 9.0 ± 7.8 | 0.257 |
| Socio-economic status | 0.005 | ||||
| Low | 83 (40.7) | 8 (34.8) | 18 (31.6) | 57 (46.0) | |
| Middle | 103 (50.5) | 9 (39.1) | 32 (56.1) | 62 (50.0) | |
| High | 18 (8.8) | 6 (26.1) | 7 (12.3) | 5 (4.0) | |
| Exposure to: | |||||
| Agrochemicals | 48 (23.5) | 0 (0.0) | 2 (3.5) | 46 (37.1) | <0.001 |
| Heavy metals | 7 (3.4) | 1 (4.3) | 6 (10.5) | 0 (0.0) | <0.001 |
| Heat | 130 (63.7) | 0 (0.0) | 9 (15.8) | 121 (97.6) | <0.001 |
| Alcohol use | 167 (81.9) | 20 (87.0) | 53 (93.0) | 96 (77.4) | 0.031 |
| Chronic use of NSAIDs | 134 (65.7) | 13 (56.5) | 39 (68.4) | 82 (66.1) | 0.589 |
| Chronic use of herbal medicines | 132 (64.7) | 15 (65.2) | 41 (71.9) | 76 (61.3) | 0.379 |
| Family history of CKD | 1 (0.5) | 0 (0.0) | 1 (1.8) | 0 (0.0) | 0.274 |
| Obesity and overweight | 64 (31.4) | 11 (47.8) | 15 (26.3) | 38 (30.6) | 0.165 |
| Mean BMI (kg/m2) | 23.8 ± 3.7 | 24.6 ± 4.4 | 23.5 ± 3.1 | 23.8 ± 3.8 | 0.516 |
| Tobacco use | 31 (15.2) | 2 (8.7) | 8 (14.0) | 21 (16.9) | 0.576 |
| Hypertension | 20 (9.8) | 4 (17.4) | 3 (5.3) | 13 (10.5) | 0.236 |
| Mean SBPa (mmHg) | 132.6 ± 15.2 | 137.1 ± 21.7 | 128.8 ± 13.4 | 133.4 ± 14.3 | 0.052 |
| Mean DBPa (mmHg) | 79.6 ± 10.1 | 83.2 ± 13.5 | 78.6 ± 9.0 | 79.4 ± 9.9 | 0.171 |
| Diabetes | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | – |
| Mean FBSa (mg/dL) | 90.3 ± 13.5 | 90.5 ± 11.9 | 94.2 ± 14.3 | 88.5 ± 13.6 | 0.458 |
| Mean RBSa (mg/dL) | 107.8 ± 20.3 | 111.5 ± 15.2 | 102.1 ± 16.5 | 109.8 ± 22.2 | 0.084 |
| Mean serum creatininea (mg/L) | 10.9 ± 1.6 | 10.6 ± 1.3 | 11.6 ± 1.5 | 10.6 ± 1.6 | <0.001 |
| Mean eGFRa (ml/min) | 109.6 ± 20.5 | 110.3 ± 21.9 | 107.9 ± 16.5 | 110.3 ± 21.9 | 0.760 |
Conversion factors for units: serum creatinine in mg/dL to μmol/L, × 88.4
BMI Body mass index CDI Permanent contract of non-specific duration, CDD Permanent contract of specific duration, CDC Temporary/seasonal contract, n: Absolute frequency, eGFR Estimated glomerular filtration rate, NSAIDs Non-steroidal anti-inflammatory drugs
aValues based on measurements at baseline
Fig. 2Prevalence of urine abnormalities: The figure shows the change in prevalence of urine abnormalities (proteinuria, hematuria and leucocyturia) over time, from baseline to 3 months later after control tests were done
Comparison of study population according to CKD status (N = 204)
| Variable | Total | CKD, | Non-CKD, | |
|---|---|---|---|---|
| Mean age (years) | 38.8 ± 9.8 | 45.1 ± 8.6 | 38.6 ± 9.8 | 0.080 |
| Mean SCr (mg/L) | 10.9 ± 1.6 | 12.6 ± 2.5 | 10.8 ± 1.5 | 0.003 |
| Mean eGFR (mg/dl) | 109.6 ± 20.5 | 94.2 ± 26.7 | 110.2 ± 20.1 | 0.042 |
| Mean eGFR2a (mg/dl) | 109.9 ± 20.1 | 102.0 ± 18.7 | 110.2 ± 20.1 | 0.325 |
| Alcohol use | 169 (81.9) | 7 (100.0) | 162 (82.2) | 0.606 |
| Chronic use of NSAIDs | 134 (65.7) | 6 (85.7) | 128 (65.0) | 0.426 |
| Chronic use of herbal medicines | 132 (64.7) | 7 (100.0) | 125 (63.5) | 0.045 |
| Overweight and obesity | 64 (31.4) | 1 (14.3) | 63 (32.0) | 0.437 |
| Tobacco use | 31 (15.2) | 2 (28.6) | 29 (14.7) | 0.288 |
| Hypertension | 20 (9.8) | 1 (14.3) | 19 (9.7) | 0.520 |
| Family history of CKD | 1 (0.5) | 0 (0.0) | 1 (0.5) | 0.966 |
CKD Chronic kidney disease, eGFR Estimated glomerular filtration rate, n Absolute frequency, NSAIDs Non-steroidal anti-inflammatory drugs
aComparison of the mean eGFRs excluding the one participant with eGFR <60 ml/min
Factors associated with chronic kidney disease
| Variable | CKD | ||||||
|---|---|---|---|---|---|---|---|
| n (%) | OR | 95% CI | AOR | 95% CI | Adjusted p | ||
| Age ≥ 40 years | 6 (85.7) | 7.5 | 0.9–60.8 | 0.032 | 18.7 | 1.5–236.4 | 0.024 |
| Male gender | 6 (85.7) | 2.0 | 0.2–16.2 | 0.442 | – | – | – |
| Middle SES | 4 (57.1) | 5.9 | 0.7–48.0 | 0.062 | 5.0 | 0.5–45.7 | 0.157 |
| Duration of employment ≥15 years | 3 (42.9) | 2.1 | 0.5–9.0 | 0.272 | 0.5 | 0.1–3.5 | 0.442 |
| Factory workspace | 4 (57.1) | 3.4 | 0.8–14.9 | 0.097 | – | – | 0.998 |
| Seasonal work contract | 4 (57.1) | 0.5 | 0.1–2.1 | 0.384 | – | – | – |
| Exposure to: | |||||||
| -Agrochemicals | 1 (14.3) | 0.5 | 0.1–4.4 | 0.480 | – | – | – |
| -Heavy metals | 0 (0.0) | – | – | 0.780 | – | – | – |
| -Heat | 4 (57.1) | 0.8 | 0.2–3.3 | 0.498 | – | – | – |
| Hypertension | 1 (14.3) | 1.5 | 0.2–12.1 | 0.520 | – | – | – |
| Use of herbal medicines | 7 (100.0) | – | – | 0.045 | – | – | – |
| Alcohol consumption | 7 (100.0) | – | – | 0.262 | – | – | – |
| Obesity and overweight | 1 (14.3) | 0.4 | 0.0–3.0 | 0.297 | 0.2 | 0.0–2.2 | 0.209 |
| NSAID use | 6 (85.7) | 3.2 | 0.4–27.4 | 0.241 | 0.4 | 0.0–3.2 | 0.350 |
| Tobacco use | 2 (28.6) | 0.4 | 0.1–2.3 | 0.288 | 0.5 | 0.1–3.1 | 0.470 |
AOR Adjusted odds ratio, CI Confidence interval, CKD Chronic kidney disease, n Absolute frequency, NSAIDs Non-steroidal anti-inflammatory drugs, OR Odds ratio, SES Socioeconomic status